PubMed Health⌕ Search

PubMed · 7639933

Host-microbe interaction in the gastrointestinal tract.

Abstract

In order for an infection to occur, the target organ must come in contact with sufficient microbes, the microbe must possess specific virulence factors, these virulence factors must be expressed, and the defenses of the organ system must be overcome. This dynamic process, which is ongoing in all living entities, can be described by the following relationship: [formula: see text] The establishment of infection first occurs in a particular organ. This phenomenon is known as tissue trophism and the association of microbes with organ systems governs the practice of clinical microbiology and infectious disease. With some microbes (e.g., Giardia, Cryptosporidium) the interaction with the particular organ is so specific that infections are almost always confined to one site; with others (e.g., Salmonella, enterovirus) the microbe has the potential to become systemic. When attempting to establish health risk assessment from microbes by contact with food and drinking water, one must therefore consider that the gastrointestinal tract is a complex organ system with a variety of specific host defense mechanisms. It is only when the microbe has particular virulence factors for sites in gastrointestinal tract, and the specific host defense mechanisms in the gastrointestinal tract are breached, that infection of this organ system occurs. Therefore, the general terms "immunosuppression" or "immunocompromise" are meaningless unless the specific immune defect is known. A description of the microbial virulence factors active against the gastrointestinal tract and the defense mechanisms of this organ system are reviewed to provide a biological basis health risk assessment and future food and drinking water regulations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H E Duncan, S C Edberg. 1995. Host-microbe interaction in the gastrointestinal tract.. https://doi.org/10.3109/10408419509113535

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Analysis of HLA class I specific antibodies in patients with failed allografts.

BACKGROUND: The goals of this study are first to determine the epitope specificity of donor specific antibody (DSA) in the serum of alloimmunized transplant patients with a failed renal graft; and second to understand the correlation between the development of DSA and nondonor specific antibody (NDSA). METHODS: The sera of 35 pretransplant panel reactive antibody (PRA)-negative patients with failed allografts were examined with single-antigen (SA) luminex beads to identify human leukocyte antigen (HLA)-A and -B antibodies. Potential HLA antibody epitopes were identified by using computer software and verified by absorption and elution from single-antigen cell lines. RESULTS: Twenty-seven patients developed donor-specific HLA-A and/or -B antibodies, while the remaining eight patients had only nondonor-specific HLA-A and/or -B antibodies. The DSA-positive patients also had a long list of NDSA. Sixty-eight percent of the reactions found in 27 recipients with DSA were attributable to 66 epitopes on the mismatched donor HLA molecule. All 39 NDSA in eight patients with only NDSA shared 17 epitopes within positive allele specificities. By absorption and elution using recombinant cell lines having a single HLA specificity, we confirmed the epitopes involved in three patients. CONCLUSION: Development of most NDSA in patients with failed allografts is likely due to sharing epitopes with DSA and/or other NDSA.

Antibody Formation↗

Human keratinocyte Toll-like receptors promote distinct immune responses.

It has been well established that Toll-like receptors (TLRs) are expressed by keratinocytes and respond to their respective ligands to initiate immune responses. However, it appears that keratinocytes, via differential activation of TLRs, may play a key role in determining the type of subsequent cutaneous immune response generated against a particular pathogen.

Antibody Formation↗